Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase II Clinical Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04992949
What this trial is testing

Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm

Who this might be right for
Acute Myeloid LeukemiaMyeloproliferative Syndrome
French Innovative Leukemia Organisation 42
Testing effectiveness (Phase 2)WithdrawnNCT04834349
What this trial is testing

Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaUnresectable Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT06085638
What this trial is testing

Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07223658
What this trial is testing

Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

Who this might be right for
Hyperlipidemia; Mixed
Arrowhead Pharmaceuticals 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07516847
What this trial is testing

Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes (MDS)Anemia
Seug yun Yoon, MD 37
Testing effectiveness (Phase 2)Looking for participantsNCT07413549
What this trial is testing

Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis

Who this might be right for
Decompensated Hepatitis B Cirrhosis
Beijing Tuohua Weiye Biotechnology Co., Ltd. 76
Testing effectiveness (Phase 2)UnknownNCT05117658
What this trial is testing

Study of HA121-28 in Patients With Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 83
Testing effectiveness (Phase 2)Looking for participantsNCT05599048
What this trial is testing

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Robert Bok, MD, PhD 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098326
What this trial is testing

CyFluATG in Lower Risk MDS

Who this might be right for
Myelodysplastic Syndromes
Asan Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT01639326
What this trial is testing

Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1

Who this might be right for
Metastatic Colorectal Cancer
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 96
Testing effectiveness (Phase 2)Study completedNCT00631878
What this trial is testing

Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110

Who this might be right for
Neonatal Staphylococcal Sepsis
Biosynexus Incorporated 53
Testing effectiveness (Phase 2)Study completedNCT00083785
What this trial is testing

Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases

Who this might be right for
Liver MetastasisColorectal NeoplasmsLiver Neoplasms+1 more
Light Sciences LLC 25
Large-scale testing (Phase 3)Study completedNCT01508455
What this trial is testing

Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age

Who this might be right for
Anesthesia
Hospira, now a wholly owned subsidiary of Pfizer 6
Testing effectiveness (Phase 2)Ended earlyNCT03911076
What this trial is testing

Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL

Who this might be right for
ASC-USASC-HLSIL
PapiVax Biotech, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT01865617
What this trial is testing

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

Who this might be right for
CD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more
Fred Hutchinson Cancer Center 204
Testing effectiveness (Phase 2)Study completedNCT02187991
What this trial is testing

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

Who this might be right for
Breast CancerBreast CarcinomaBreast Tumors+1 more
US Oncology Research 169
Testing effectiveness (Phase 2)UnknownNCT03168074
What this trial is testing

Phase II Study of Single Agent Lenvatinib

Who this might be right for
Breast Cancer
National University Hospital, Singapore 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06858618
What this trial is testing

FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms

Who this might be right for
SafetyAntitumor ActivityPK Profile
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07279597
What this trial is testing

A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle-invasive Bladder Urothelial Carcinoma
Tongji Hospital 45
Testing effectiveness (Phase 2)Study completedNCT05619913
What this trial is testing

EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma

Who this might be right for
Ovarian CarcinosarcomaUterine Carcinosarcoma
Australia New Zealand Gynaecological Oncology Group 13
Next Page